SEC Form 4 reporting owner

Sukhtian Ghiath M.

Sukhtian Ghiath M. has filed 4 Form 4 transactions reported between May 28, 2026 and August 12, 2026, as a reporting owner of Outlook Therapeutics, Inc..

Name as filed: Sukhtian Ghiath M.

Open-market buys, 24 mo
$7.5M
2 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Aug 12, 2026
transaction date

Roles and reported holdings

  • OTLKOutlook Therapeutics, Inc.
    May 28, 2026 – Aug 12, 2026

    Reporting owner

    Held indirectly (latest line)24,617,320 sh as of Aug 12, 2026 · Form 4

    24 months: $7.5M bought

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 12, 2026OTLKOpen-market purchaseCode P · indirect2,525,252$2.5M@ $0.9900Form 4
May 28, 2026OTLKExpiration of long derivativeCode H · indirect8,571,428—Form 4
May 28, 2026OTLKExpiration of long derivativeCode H · indirect3,458,571—Form 4
May 28, 2026OTLKOpen-market purchaseCode P · indirect8,539,709$5.0M@ $0.5855Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.